By Aeisya Mardhiyyah
KUALA LUMPUR, 20 January 2022: Starting February, the government will be inoculating children aged between 5 and 11 years old with the COVID-19 vaccine.
The Special Committee on COVID-19 Vaccine Supply Access Guarantee (JKJAV), through a tweet, said children will only receive paediatric doses of Pfizer-BioNTech’s Cominarty vaccine which is proven to be safe and effective.
The paediatric dose is a smaller dose of the vaccine, equivalent to one-third of the dosage given to individuals aged 12 and above.
JKJAV said clinical trials found that the risk of symptomatic COVID-19 infection in vaccinated children is reduced by 90 per cent.
Common post-vaccination side effects, it said, are generally mild and moderate in children while severe adverse reactions are rare.
JKJAV said children with comorbidities or those at high risk of contracting severe COVID-19 infections will be prioritised for vaccination.
However, children with a history of severe allergies (anaphylaxis) against medicines, food or unknown ingredients will not be given the jabs.
Likewise, children who develop allergic reactions within 72 hours after receiving their first dose or those with allergies against any ingredients of the COVID-19 vaccine will not be given a second dose.
The Drug Control Authority on 6 January granted conditional approval for the Cominarty vaccine to be used on children aged between 5 and 11.
Minister of Health, Khairy Jamaluddin also said that the ministry has formed the COVID-19 Immunisation Task Force-Children (CITF-C) to coordinate the COVID-19 vaccination programme for children.***
Source: New Straits Time
- Six Malaysian students accepted into Harvard amidst stiff competition - April 6, 2022
- Malaysia backs vote against Russia at UN special session - March 3, 2022
- Children aged 5-11 to get Pfizer jabs in February - January 20, 2022